West Pharmaceutical Services Inc. Stock Rises 4.8%, Outperforms Competitors

Dow Jones
02-25

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of West Pharmaceutical Services Inc. rose 4.8% to $221.07 on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.1% to 43,461.21 and the S&P 500 Index falling 0.5% to 5,983.25.

This was the stock's third consecutive day of gains.

West Pharmaceutical Services Inc. closed 44.9% below its 52-week high of $400.88, which the company reached on March 21st.

The stock outperformed some of its competitors, as Abbott Laboratories remained unchanged, Becton Dickinson & Co. rose 1.3% to $230.31, and Baxter International Inc. rose 3.73% to $35.08.

Trading volume totaled 1.5 million, compared to the 50-day average of 807,651.

Data source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

February 24, 2025 16:34 ET (21:34 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10